2021 annual financial data

Sutro Biopharma 2021 Operating margin

Direct answer

Operating margin was -159.22%.

Operating income was -98.52M USD and net income was -105.54M USD.
Operating cash flow was -81.68M USD.

Get free Sutro Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
61.88M USD
Operating income
-98.52M USD
Net income
-105.54M USD
Operating cash flow
-81.68M USD